AAP
IMA

Arax Advisory Partners’s ImageneBio Inc IMA Stock Holding History

Arax Advisory Partners’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$386 – 2864
2024
Q4 		$386 Sell
20
-5
-20% -$101 ﹤0.01% 2344
2024
Q3 		$518 Hold
25
– – ﹤0.01% 2396
2024
Q2 		$494 Buy
+25
New +$441 ﹤0.01% 2332

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Arax Advisory Partners's IMA Position: Q1 2025 in Review

Arax Advisory Partners sold out of ImageneBio Inc (IMA) in Q1 2025, closing a stake of 20 shares — an estimated $386 sold.

Arax Advisory Partners first reported a position in IMA in Q2 2024 and held it in 3 quarters. The position peaked at $518 in Q3 2024. 45 funds tracked by Wall St. Rank hold IMA as of Q1 2025.

  • Arax Advisory Partners reported no remaining ImageneBio Inc position as of Q1 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 20 ImageneBio Inc shares in Q1 2025, an estimated $386.
  • Arax Advisory Partners first reported a position in ImageneBio Inc in Q2 2024 and held it in 3 quarters.
  • Arax Advisory Partners's ImageneBio Inc position peaked at $518 in Q3 2024.
  • 45 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2025.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.